Open AccessThe SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment‐naïve patients
Author(s) -
Stellbrink HJ,
Rugina S,
Zagler C,
Esser S,
Castagna A,
Gazzard B,
Hill A,
Delft Y,
Marks S
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-o47
Subject(s) - efavirenz , medicine , etravirine , adverse effect , psychiatry , human immunodeficiency virus (hiv) , pediatrics , antiretroviral therapy , family medicine , viral load
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK